Skip to main content
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 1998 Apr;24(2):99–105. doi: 10.1136/jme.24.2.99

Francis Galton: and eugenics today.

D J Galton 1, C J Galton 1
PMCID: PMC1377454  PMID: 9602996

Abstract

Eugenics can be defined as the use of science applied to the qualitative and quantitative improvement of the human genome. The subject was initiated by Francis Galton with considerable support from Charles Darwin in the latter half of the 19th century. Its scope has increased enormously since the recent revolution in molecular genetics. Genetic files can be easily obtained for individuals either antenatally or at birth; somatic gene therapy has been introduced for some rare inborn errors of metabolism; and gene manipulation of human germ-line cells will no doubt occur in the near future to generate organs for transplantation. The past history of eugenics has been appalling, with gross abuses in the USA between 1931 and 1945 when compulsory sterilization was practised; and in Germany between 1933 and 1945 when mass extermination and compulsory sterilization were performed. To prevent such abuses in the future statutory bodies, such as a genetics commission, should be established to provide guidance and rules of conduct for use of the new information and technologies as applied to the human genome.

Full text

PDF
101

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  2. Galton D. J., Galton C. J. Francis Galton: his approach to polygenic disease. J R Coll Physicians Lond. 1997 Sep-Oct;31(5):570–573. [PMC free article] [PubMed] [Google Scholar]
  3. Giardiello F. M., Brensinger J. D., Petersen G. M., Luce M. C., Hylind L. M., Bacon J. A., Booker S. V., Parker R. D., Hamilton S. R. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. 1997 Mar 20;336(12):823–827. doi: 10.1056/NEJM199703203361202. [DOI] [PubMed] [Google Scholar]
  4. Hanauske-Abel H. M. Not a slippery slope or sudden subversion: German medicine and national socialism in 1933. BMJ. 1996 Dec 7;313(7070):1453–1463. doi: 10.1136/bmj.313.7070.1453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Humphries S. E., Galton D., Nicholls P. Genetic testing for familial hypercholesterolaemia: practical and ethical issues. QJM. 1997 Mar;90(3):169–181. doi: 10.1093/qjmed/90.3.169. [DOI] [PubMed] [Google Scholar]
  6. Humphries S., Betteridge D. J., Durrington P. N., Galton D. J., Nicholls P. Apolipoprotein E genotyping in Alzheimer's disease. Lancet. 1996 Jun 22;347(9017):1776–1776. [PubMed] [Google Scholar]
  7. Lovestone S., Wilcock G., Rossor M., Cayton H., Ragan I. Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium. Lancet. 1996 Jun 22;347(9017):1775–1776. [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES